GlaxoSmithKline settles healthcare fraud case for $3 billion

A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company resultsWASHINGTON (Reuters) – GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S. history. The agreement, which still needs court approval, would resolve allegations that the British drugmaker broke U.S. laws in the marketing and development of pharmaceuticals. …